BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs4950928
,
FGF21
,
Apoptosis
,
Influenza
,
Embryo
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antineoplastic agents, hormonal
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
FKBP5
TSC22D3
PDK4
ZBTB16
CCL2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
DODD_NASOPHARYNGEAL_CARCINOMA_DN
PILON_KLF1_TARGETS_DN
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
PUJANA_BRCA1_PCC_NETWORK
organic cyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Primary, metastatic and recurring breast cancers with ER, PR, HER2 status and molecular subtypes
Cervical gene expression profiles in late pregnant dams treated with MPA
Cellular response phenotypes to glucocorticoid treatment
MCF7 tumor xenografts treated with BMS754807, Tamoxifen or Letrozole
Cryptochromes mediate rhythmic repression of the glucocorticoid receptor
Explore Curated Studies Results
Literature
Most Relevant Literature
The development of endocrine therapy for women with breast cancer.
More patients can benefit from existing breast cancer drugs.
Endocrine therapy in breast cancer: efficacy and adverse events].
Landmarks in hormonal therapy for prostate cancer.
Reply: Landmarks in hormonal therapy for prostate cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents i…
BI-1808 as a Single Agent and With Pembrolizumab in Treatment of Advanced Malignancies(Keynote-D20)
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Ca…
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Lo…
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to O…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ